Identification of beta-aminopyrrolidine containing peptides as beta-amyloid aggregation inhibitors for Alzheimer's disease

Preetham, H. D. and Umashankara, M. and Sharath Kumar, K. S. and Shobith, R. and Rangappa, K. S. (2022) Identification of beta-aminopyrrolidine containing peptides as beta-amyloid aggregation inhibitors for Alzheimer's disease. Journal of Peptide Science, 28 (6). ISSN 1099-1387

Full text not available from this repository. (Request a copy)
Official URL: https://doi.org/10.1002/psc.3386

Abstract

Alzheimer's disease (AD) is caused by a series of events initiated by the production and aggregation of the amyloid beta-protein (A beta). In the early stages of the disease, A beta is released in a soluble form then progressively forms oligomeric, multimeric, and fibrillar aggregates, triggering neurodegeneration. Thus, development of inhibitors that initiate reverse A beta aggregation is thought to be a logical approach in treating AD. In this context, we developed beta-aminopyrrolidine containing 12 mer peptide 3 which is very potent in inhibiting the A beta aggregation and also reducing A beta(42)-induced cytotoxicity.

Item Type: Article
Uncontrolled Keywords: Alzheimer's disease; amyloid beta-protein; amyloid beta aggregation; beta-aminopyrrolidine
Subjects: C Chemical Science > Chemistry
Divisions: Department of > Chemistry
Depositing User: C Swapna Library Assistant
Date Deposited: 20 Jul 2023 07:04
Last Modified: 20 Jul 2023 07:04
URI: http://eprints.uni-mysore.ac.in/id/eprint/17657

Actions (login required)

View Item View Item